SCHEMBL3520987

SCHEMBL3520987

Cc1nc2ccccc2nc1C(=O)OO

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 5/20 0.46
POLB P06746 1/20 0.46
CYP1A2 P05177 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.42
PDE10A Q9Y233 1/20 0.42
TSHR P16473 2/20 0.41
TP53 P04637 2/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTT P42858 1/20 0.41
GAA P10253 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6386134 0.85 SMN1; SMN2 (0.56) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL2025252 0.82 LMNA (0.57) MAPTSMN1; SMN2ALDH1A1KDM4EPOLB
SCHEMBL2056931 0.79 ALDH1A1 (0.72) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL29670121 0.79 ALDH1A1 (0.72) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL4833903 0.79 MAPT (0.54) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL28033469 0.77 L3MBTL1 (0.53) MAPTSMN1; SMN2ALDH1A1KDM4EMEN1
SCHEMBL6387026 0.77 MAPT (0.52) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL4396535 0.77 MAPT (0.52) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL11775934 0.76 CYP3A4 (0.53) MAPTSMN1; SMN2ALDH1A1KDM4EMEN1
SCHEMBL11177962 0.74 HTT (0.58) MAPTSMN1; SMN2ALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227770-A2 PROLYL HYDROXYLASE INHIBITORS GlaxoSmithKline LLC (US) 2010-09-15 EP disclosed
WO-2009073497-A2 PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-11 WO disclosed